Výsledky vyhledávání - "Cira Riccardi"

Akademický článek

Case report: Donor lymphocyte infusion and blinatumomab as treatment for acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation

Autor: Flavia Antonucci, Serena Marotta, Maria Celentano, Mariangela Pedata, Cira Riccardi, Cristina Luise, Angela Carobene, Simona Maria Muggianu, Assunta Viola, Mafalda Caputo, Stefania Leone, Ilaria Migliaccio, Barbara Pocali, Mirella Alberti, Claudio Falco, Mario Toriello, Felicetto Ferrara, Alessandra Picardi

Publikováno v: Frontiers in Hematology, Vol 3 (2024)

To date, the effect of blinatumomab and donor lymphocyte infusion association as a salvage treatment for acute lymphoblastic leukemia (ALL) relapse after allogeneic transplant procedure is still unknown. Here, we report a case report of a patient wit

Externí odkaz: https://doaj.org/article/696d4a34f3cc49e0827dfbf48df98890

Zobrazit plný text záznamu

Is chemotherapy really the best option in older adults with acute myeloid leukemia?

Autor: Felicetto Ferrara, Cira Riccardi, Piera Angelillo, Antonella Carbone

Publikováno v: International Journal of Hematologic Oncology. 2:355-358

“…more than half of acute myeloid leukemia diagnoses are made in patients older than 65 years … therefore treatment of the disease in advanced age represents a daily challenge in clinical hematology … A major dilemma in older patients is whet

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e9b561a7e343740501d39df32314a014
https://doi.org/10.2217/ijh.13.44

Zobrazit plný text záznamu

Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: Feasibility, toxicity, and therapeutic results

Autor: Felicetto Ferrara, Tiziana Izzo, Maria Celentano, Giuseppina Mele, Cira Riccardi, Clelia Criscuolo

Publikováno v: American Journal of Hematology. 85:687-690

The strategy named double induction (DI) in acute myeloid leukemia (AML) consists of two courses of chemotherapy irrespective of the degree of cytoreduction in the bone marrow (BM) after the first course, unless severe complications prohibit its appl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dc2e17bad65dbb3906466d246859aef
https://doi.org/10.1002/ajh.21791

Zobrazit plný text záznamu

VTD (Bortezomib Plus Thalidomide Plus Dexamethasone) Followed By Autologous Stem Cell Transplantation As First Line Treatment for Multiple Myeloma: Real Life Results from a Single Institution

Autor: Felicetto Ferrara, Angela Gravetti, Salvatore Palmieri, Cira Riccardi, Antonella Carbone, Giuseppe Monaco, Stefano Rocco, Carolina Copia, Fioravante Ronconi

Publikováno v: Blood. 126:5380-5380

BACKGROUND. In recent years, new classes of drugs have been introduced for the treatment of Multiple myeloma (MM). Several randomized trials have investigated, in the setting of first line treatment of patients eligible for autologous transplant (ASC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f853d3863b5ac7dc7a6398f40b86224f
https://doi.org/10.1182/blood.v126.23.5380.5380

Zobrazit plný text záznamu

Continuous sequential infusion of fludarabine and cytarabine for elderly patients with acute myeloid leukaemia secondary to a previously diagnosed myelodysplastic syndrome

Autor: Felicetto Ferrara, Cira Riccardi, Tiziana Izzo, Salvatore Palmieri, Clelia Criscuolo

Publikováno v: Hematological oncology. 28(4)

Acute myeloid leukaemia (AML) secondary to myelodysplastic syndrome (MDS) is characterized by poor prognosis, namely in older patients. The combination of fludarabine (F) with cytarabine (ARA-C) ± G-CSF was proven as effective in patients with poor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f352e0d41ffec2bde93f305ee3f27328
https://pubmed.ncbi.nlm.nih.gov/21136583

Zobrazit plný text záznamu

Autologous stem cell transplantation for patients with acute promyelocytic leukemia in second molecular remission

Autor: Felicetto, Ferrara, Olimpia, Finizio, Tiziana, Izzo, Cira, Riccardi, Clelia, Criscuolo, Antonella, Carbone, Erika, Borlenghi, Giuseppe, Rossi

Publikováno v: Anticancer research. 30(9)

Relapse still occurs in approximately 20-30% of patients with acute promyelocytic leukemia (APL) and, after achievement of second complete remission (CR), the optimal strategy is still controversial. We describe therapeutic results from a series of 1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::64dd84f8f832fb91e748b44d70ef5540
https://pubmed.ncbi.nlm.nih.gov/20944181

Zobrazit plný text záznamu

Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis

Autor: Antonella Carbone, Assunta Viola, Maria Celentano, Tiziana Izzo, Rossella D'Elia, Cira Riccardi, Clelia Criscuolo, Felicetto Ferrara

Publikováno v: Hematological oncology. 29(3)

Different authors have explored the feasibility of autografting patients with multiple myeloma (MM) on an outpatient basis. Peg-filgrastim (PEG), a long-acting recombinant G-CSF, has similar efficacy when compared to conventional G-CSF for chemothera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::936323ee8efbcceb740e69a16d01786a
https://pubmed.ncbi.nlm.nih.gov/21922508

Zobrazit plný text záznamu

Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan

Autor: Fabrizio Pane, Cira Riccardi, Clelia Criscuolo, Tiziana Izzo, Assunta Viola, Felicetto Ferrara, Salvatore Palmieri, Giada Casadei Muccioli

Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(7)

Mutations of the nucleophosmin gene (NPM1), in the absence of concurrent FLT3-internal tandem duplication (FLT3-ITD) have impressive prognostic value in patients with acute myelogenous leukemia (AML), carrying normal karyotype (NK). In this study we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6766a00b43fe95cd634de736cc13e25f
https://pubmed.ncbi.nlm.nih.gov/20172040

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání